News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Nicholas DeVito: Gli2 promotes tumor immune evasion and immunotherapy resistance through Wnt and Prostaglandin signaling
Nicholas DeVito/scholars.duke.edu
Feb 26, 2025, 10:32

Nicholas DeVito: Gli2 promotes tumor immune evasion and immunotherapy resistance through Wnt and Prostaglandin signaling

Nicholas DeVito, Assistant Professor of Medicine at Duke University, Division of Medical Oncology, shared a paper he and his colleagues authored on LinkedIn:

“After 7 years of work our manuscript is published in Cancer Research

Here we describe how the hedgehog pathway transcription factor Gli2 promotes tumor immune evasion and immunotherapy resistance through Wnt and Prostaglandin signaling, which can be overcome with clinical pharmacologic inhibitors.

See the tutorial on BlueSky here.”

Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling

Authors: Nicholas C DeVito et al.

Nicholas DeVito

Balamayooran Theivanthiran Brent A. Hanks cancer Georgia M. Beasley Kaylee A. Villarreal Michael Aksu Michael P. Plebanek Michael Sturdivant Nagendra Yarla Nicholas C. DeVito OncoDaily Oncology Vaibhav Jain Y-Van Nguyen
Special Coverage
Blog
Apr 1, 2025, 07:32
Shravan Nadkarni: Registration is open for the Laparoscopic Colorectal Surgery Live Workshop
Science
Apr 1, 2025, 07:29
Talha Badar: Predictors of CNS relapse in APL
Blog
Apr 1, 2025, 07:24
Jenny Seligmann: World-class discovery science and clinicians collaborating on colorectal trial cohorts
Opinion
Apr 1, 2025, 07:19
Yüksel Ürün: Low-dose CT for lung cancer screening in a high-risk population
Blog
Apr 1, 2025, 07:09
Virginia Galvín: Should critical medications be integrated into defense budgets?
Blog
Apr 1, 2025, 06:51
Kendra Paabo: The 3 worst words you can say to someone with cancer
Blog
Apr 1, 2025, 06:49
Ali Atoui: Honored to Receive the 2025 CHAMP Award from the American Society of Hematology
Drugs
Apr 1, 2025, 06:49
Tislelizumab (Tevimbra): What Patients need to know?
Blog
Apr 1, 2025, 06:34
Trainee Day provided a space for trainees to connect and grow within the EBMT community
Blog
Apr 1, 2025, 06:20
Abhishek Chatterjee: The inaugural Stryker Breast Care Oncoplastic Surgery course has finished
Insight
Apr 1, 2025, 04:51
MD Anderson Cancer Center broke ground on a new 470,000-square-foot facility in Sugar Land
Blog
Apr 1, 2025, 04:49
Katy Beckermann: Secondary Analysis of the TITAN Trial